336 related articles for article (PubMed ID: 26327487)
1. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust.
Giesinger JM; Kieffer JM; Fayers PM; Groenvold M; Petersen MA; Scott NW; Sprangers MA; Velikova G; Aaronson NK;
J Clin Epidemiol; 2016 Jan; 69():79-88. PubMed ID: 26327487
[TBL] [Abstract][Full Text] [Related]
2. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies.
Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J
Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068
[TBL] [Abstract][Full Text] [Related]
3. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
[TBL] [Abstract][Full Text] [Related]
4. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
[TBL] [Abstract][Full Text] [Related]
5. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
[TBL] [Abstract][Full Text] [Related]
6. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
[TBL] [Abstract][Full Text] [Related]
7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
8. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
9. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
[TBL] [Abstract][Full Text] [Related]
10. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the EORTC QLQ-C30 in Uganda.
Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
[TBL] [Abstract][Full Text] [Related]
12. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
13. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
[TBL] [Abstract][Full Text] [Related]
14. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer.
Viada C; Bouza C; Fors M; Frías A; Alvarez M; García L; Wilkinson B; Rodríguez C; Crombet T; Ballesteros J
Qual Life Res; 2020 Dec; 29(12):3441-3448. PubMed ID: 33136243
[TBL] [Abstract][Full Text] [Related]
15. Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needs.
Snyder CF; Blackford AL; Sussman J; Bainbridge D; Howell D; Seow HY; Carducci MA; Wu AW
Qual Life Res; 2015 May; 24(5):1207-16. PubMed ID: 25398495
[TBL] [Abstract][Full Text] [Related]
16. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
[TBL] [Abstract][Full Text] [Related]
17. Conceptual structure of the Taiwan Chinese version of the EORTC QLQ-C30.
Huang CC; Tu SH; Lien HH; Huang CS; Wang PC; Chie WC
Qual Life Res; 2015 Aug; 24(8):1999-2013. PubMed ID: 25560775
[TBL] [Abstract][Full Text] [Related]
18. Normative data for the EORTC QLQ-C30 from the Austrian general population.
Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
[TBL] [Abstract][Full Text] [Related]
19. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
[TBL] [Abstract][Full Text] [Related]
20. Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis.
Costa DS; Aaronson NK; Fayers PM; Pallant JF; Velikova G; King MT
Qual Life Res; 2015 Jan; 24(1):125-33. PubMed ID: 25193618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
